Nalbuphine
Back to searchMolecule Structure
Scientific Name
Nalbuphine
Description of the Drug
Nalbuphine is an opioid agonist-antagonist used to treat pain, for pre and postoperative analgesia, and for analgesia in labor and delivery.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00844
http://www.drugbank.ca/drugs/DB00844
Brand Name(s)
Not Available
Company Owner(s)
Igi Laboratories Inc, Hospira Inc, Par Pharmaceutical Inc, Abraxis Pharmaceutical Products, Abbvie Inc, Dr Reddys Laboratories Ltd, Abbott Laboratories Hosp Products Div, Rising Pharma Holdings Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Opioid receptors; mu/kappa/delta | PROTEIN FAMILY | AGONIST | CHEMBL2095181 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL3766 | |
Human Metabolome Database | HMDB0014982 | |
DrugBank | DB00844 | |
PubChem: Thomson Pharma | 14828107 | 14828108 |
PubChem | 5311304 | |
LINCS | LSM-3477 | |
Nikkaji | J14.212C | |
BindingDB | 50105085 | |
EPA CompTox Dashboard | DTXSID8023345 | |
DrugCentral | 1874 | |
Brenda | 147356 | |
Guide to Pharmacology | 1663 | |
rxnorm | NALBUPHINE HYDROCHLORIDE | NALBUPHINE |
KEGG Ligand | C07251 | |
ChEBI | 7454 | |
ZINC | ZINC000003812989 |